Ito Nobuyuki, Tsuda Hiroyuki, Hasegawa Ryohei, Imaida Katsumi
Department of Pathology, Nagoya City University Medical school, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya 467, Japan.
Toxicol Pathol. 1982 Feb;10(2):37-47. doi: 10.1177/019262338201000207.
The aims of this study were 1) to observe the sequential development of hepatocellular carcinomas from preneoplastic lesions and to investigate hyperplastic (neoplastic) foci or nodules (HN) as an indicator of a preneoplastic population, and 2) to test the promoting effect of various agents and to study the dose-dependent effect of promoting agents in the induction of preneoplastic lesions in the rat liver. 1) F344 rats were injected with N-nitrosodiethylamine (DEN) and then given basal diet containing 2-acetylaminofluorene (2-AAF) or α-hexachlorocyclohexane (α-HCH). Two-thirds partial hepatectomy (PH) was performed at the end of week 3. Animals were killed periodically for quantitative analysis of HN and for study of changes in blood supply to the lesions by method using a resin. In the liver of rats treated with 2-AAF after DEN, the number and area of HN were maximal in week 10, and then the number gradually decreased to week 50 (P < 0.001), whereas the area remained almost constant. In the group given α-HCH after DEN, the number of HN decreased temporarily in week 20 and then gradually increased, whereas the area of HN increased slowly throughout the experiment. Histological examination suggested that the decrease of HN after week 10 was due to degeneration of HN with their change to a spongy or cystic appearance, and that the degeneration resulted from circulatory disturbance. The number and area of these degenerating hyperplastic nodules (DHN) increased reciprocally to the decrease of HN with time until week 30. The number of hepatocellular carcinomas was maximal at week 40. The blood supply to the early hyperplastic nodules was mainly through the portal vein as with normal or surrounding liver tissue, but at a later stage HN and hepatocellular carcinomas were supplied with a blood mainly from the hepatic artery. Therefore, arterial blood supply seemed important for the persistence of HN and development of hepatocellular carcinoma. Most of the HN which appeared within the first 10 weeks were histochemically positive for γ-glutamyl-transpeptidase (γ-GT) activity. This experiment showed that detectable preneoplastic lesions measured as γ-GT positive foci or HN were induced by exposure to promoting agents for 6 to 10 weeks after initiation with DEN. 2) In tests of the promoting activity and dose-dependent effect of various compounds, rats were injected intraperitoneally with DEN and given the test compounds for 6 to 10 weeks and then killed. PH was performed as in experiment 1. Potent hepatocarcinogens, such as 2-AAF, 3'-methyl-4-dimethylaminoazobenzene (3'-Me-DAB), ethionine and N-nitrosodimethylamine (DMN), induced a large number and area of HN or γ-GT positive foci whereas weak ones, such as α-HCH, dieldrin, hormones and bile acids evoked less response. Both potent and weak carcinogens showed a clear dose-dependent effect. A similar dose-dependent effect was also shown in the induction of hepatocellular carcinoma in a long-term experiment by continuous feeding of DMN. Non-hepatocarcinogens, such as N-ethylnitrosourea (ENU) and 3-methylcholanthrene (3-MC) induced them only in small numbers.
1)观察肝细胞癌从癌前病变的连续发展过程,并研究增生性(肿瘤性)病灶或结节(HN)作为癌前细胞群的指标;2)测试各种试剂的促癌作用,并研究促癌剂在诱导大鼠肝脏癌前病变中的剂量依赖性效应。1)给F344大鼠注射N-亚硝基二乙胺(DEN),然后给予含2-乙酰氨基芴(2-AAF)或α-六氯环己烷(α-HCH)的基础饲料。在第3周结束时进行三分之二肝部分切除术(PH)。定期处死动物,对HN进行定量分析,并通过使用树脂的方法研究病变血供的变化。在DEN处理后用2-AAF处理的大鼠肝脏中,HN的数量和面积在第10周时最大,然后数量逐渐减少至第50周(P<0.001),而面积几乎保持不变。在DEN处理后给予α-HCH的组中,HN的数量在第20周时暂时减少,然后逐渐增加,而HN的面积在整个实验过程中缓慢增加。组织学检查表明,第10周后HN数量的减少是由于HN退变,变为海绵状或囊性外观,且这种退变是由循环障碍导致的。这些退变增生性结节(DHN)的数量和面积随时间与HN数量的减少呈反比增加,直至第30周。肝细胞癌的数量在第40周时最多。早期增生性结节的血供主要通过门静脉,与正常或周围肝组织一样,但在后期,HN和肝细胞癌主要由肝动脉供血。因此,动脉血供似乎对HN的持续存在和肝细胞癌的发展很重要。在最初10周内出现的大多数HN在组织化学上γ-谷氨酰转肽酶(γ-GT)活性呈阳性。该实验表明,以γ-GT阳性病灶或HN衡量的可检测到的癌前病变是在DEN启动后暴露于促癌剂6至10周诱导产生的。2)在各种化合物的促癌活性和剂量依赖性效应测试中,给大鼠腹腔注射DEN,并给予测试化合物6至10周,然后处死。如实验1中那样进行PH。强效肝癌致癌物,如2-AAF、3'-甲基-4-二甲基氨基偶氮苯(3'-Me-DAB)、乙硫氨酸和N-亚硝基二甲胺(DMN),诱导出大量且面积较大的HN或γ-GT阳性病灶,而弱效致癌物,如α-HCH、狄氏剂、激素和胆汁酸引起的反应较小。强效和弱效致癌物均显示出明显的剂量依赖性效应。在通过持续喂食DMN进行的长期实验中,诱导肝细胞癌时也显示出类似的剂量依赖性效应。非肝癌致癌物,如N-乙基亚硝基脲(ENU)和3-甲基胆蒽(3-MC)仅诱导出少量病变。